Adjuvant Oral Chemo in Biliary Tract Cancer Extended Survival

The addition of adjuvant oral chemotherapy with capecitabine extended the overall survival of patients with biliary cancers by a median of 15 months, according to the results of the BILCAP study.

Source: CancerNetwork - May 18, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Conferences/ASCO Gastrointestinal Cancer Liver, Gallbladder, and Biliary Tract Cancers News Source Type: news